Evoxac and Methylprednisolone sodium succinate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Evoxac (cevimeline hydrochloride) and Methylprednisolone sodium succinate (methylprednisolone sodium succinate). Common drug interactions include hyperlipidaemia among females.

The phase IV clinical study analyzes what interactions people have when they take Evoxac and Methylprednisolone sodium succinate. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Evoxac?

Evoxac has active ingredients of cevimeline hydrochloride. It is often used in sjogren syndrome. eHealthMe is studying from 2,028 Evoxac users. Check the latest studies of Evoxac.

What is Methylprednisolone sodium succinate?

Methylprednisolone sodium succinate has active ingredients of methylprednisolone sodium succinate. eHealthMe is studying from 18,163 Methylprednisolone sodium succinate users. Check the latest studies of Methylprednisolone sodium succinate.

On Aug, 04, 2026

14 people who take Evoxac and Methylprednisolone sodium succinate together, and have interactions are studied.

Evoxac and Methylprednisolone sodium succinate drug interactions.

What are the common drug interactions of Evoxac and Methylprednisolone Sodium Succinate, by gender? *:

female:

Hyperlipidaemia (presence of excess lipids in the blood)
Nasopharyngitis (inflammation of the nasopharynx)
Rhinitis allergic (inflammation of the nasal airways due to allergy)
Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
Lupus nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue)
Anaemia (lack of blood)
Fungal skin infection
Herpes zoster
Hypertension (high blood pressure)
Ovarian cyst (fluid filled sac of the ovary)

male:

n/a

What are the common drug interactions of Evoxac and Methylprednisolone Sodium Succinate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Blood creatine phosphokinase increased
Gastroenteritis (inflammation of stomach and intestine)
Hyperlipidaemia (presence of excess lipids in the blood)
Hyperuricaemia (level of uric acid in the blood that is abnormally high)
Iron deficiency anaemia
Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)
Nasopharyngitis (inflammation of the nasopharynx)
Osteonecrosis (death of bone)
Otitis externa (external ear infection)
Purpura (purplish discoloration of the skin)

30-39:

Hypertension (high blood pressure)
Ovarian cyst (fluid filled sac of the ovary)
Upper respiratory tract inflammation
Nasopharyngitis (inflammation of the nasopharynx)
Rash
Endometrial cancer
Abdominal distension
Diarrhoea
Upper respiratory tract infection
Viral upper respiratory tract infection

40-49:

n/a

50-59:

Anaemia (lack of blood)
Dehydration (dryness resulting from the removal of water)
Failure to thrive (inadequate weight gain and physical growth in children)
Lymphoma (cancer that begins in immune system cells)
Thrombocytopenia (decrease of platelets in blood)
Weight decreased

60+:

n/a

What are the existing conditions these people have? *

Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 13 people, 92.86%
Hyperlipidaemia (presence of excess lipids in the blood): 11 people, 78.57%
Nasopharyngitis (inflammation of the nasopharynx): 10 people, 71.43%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 7 people, 50.00%
Joint Pain: 6 people, 42.86%
Anaemia (lack of blood): 6 people, 42.86%
Cough: 6 people, 42.86%
Dry Mouth: 6 people, 42.86%
Fever: 6 people, 42.86%
Fungal Skin Infection: 6 people, 42.86%

* Approximation only. Some reports may have incomplete information.

Do you take Evoxac and Methylprednisolone sodium succinate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously